The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-IgG antibody Market Research Report 2025

Global Anti-IgG antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1897610

No of Pages : 103

Ask Your Query
Synopsis
Anti-IgG Antibody is a type of antibody that specifically binds to IgG, which is one of the major classes of antibodies produced by the immune system. IgG antibodies are involved in immune responses by recognizing and neutralizing foreign substances, such as bacteria and viruses. Anti-IgG antibodies are used in research and diagnostic applications to detect the presence of IgG in samples which can indicate an immune response or the presence of certain diseases. They are also used in therapeutics, such as immune globulins, which are used to treat conditions like primary immunodeficiency and certain autoimmune diseases.
The global Anti-IgG antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for Anti-IgG Antibody has experienced steady growth due to its essential role in immunology research and diagnostics. The antibody is crucial for developing and validating assays that detect and measure IgG antibodies, which are important biomarkers for monitoring immune status and disease progression. Additionally, the use of Anti-IgG the development of therapeutics, such as passive immunotherapy and targeted drug delivery systems, is expected to drive the demand for this product. As the field of personalized medicine advances, the utility of Anti-IgG Antibody in patient diagnosis and treatment is expected to further propel its industry trend.
This report aims to provide a comprehensive presentation of the global market for Anti-IgG antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-IgG antibody.
Report Scope
The Anti-IgG antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-IgG antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-IgG antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BosterBio
Bio-Rad
ProSci
BD Biosciences
Biorbyt
R&D Systems
Bethyl Laboratories
Dianova
BioLegend
Abbexa
SouthernBiotech
Thermo Fisher Scientific
Immundiagnostik
MyBioSource
BMA Biomedicals
Novus Biologicals
Cell Sciences
Rockland Immunochemicals
QED Bioscience
Miltenyi Biotec
Jackson ImmunoResearch Laboratories
Advansta
Affinity Immuno
Antigenix America
Promega
Abeomics
Anogen
AIVD Biotech
Sino Biological
Tonbo Biosciences
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-IgG antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-IgG antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-IgG antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-IgG antibody Market Perspective (2019-2030)
2.2 Anti-IgG antibody Growth Trends by Region
2.2.1 Global Anti-IgG antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-IgG antibody Historic Market Size by Region (2019-2024)
2.2.3 Anti-IgG antibody Forecasted Market Size by Region (2025-2030)
2.3 Anti-IgG antibody Market Dynamics
2.3.1 Anti-IgG antibody Industry Trends
2.3.2 Anti-IgG antibody Market Drivers
2.3.3 Anti-IgG antibody Market Challenges
2.3.4 Anti-IgG antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-IgG antibody Players by Revenue
3.1.1 Global Top Anti-IgG antibody Players by Revenue (2019-2024)
3.1.2 Global Anti-IgG antibody Revenue Market Share by Players (2019-2024)
3.2 Global Anti-IgG antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-IgG antibody Revenue
3.4 Global Anti-IgG antibody Market Concentration Ratio
3.4.1 Global Anti-IgG antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-IgG antibody Revenue in 2023
3.5 Anti-IgG antibody Key Players Head office and Area Served
3.6 Key Players Anti-IgG antibody Product Solution and Service
3.7 Date of Enter into Anti-IgG antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-IgG antibody Breakdown Data by Type
4.1 Global Anti-IgG antibody Historic Market Size by Type (2019-2024)
4.2 Global Anti-IgG antibody Forecasted Market Size by Type (2025-2030)
5 Anti-IgG antibody Breakdown Data by Application
5.1 Global Anti-IgG antibody Historic Market Size by Application (2019-2024)
5.2 Global Anti-IgG antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-IgG antibody Market Size (2019-2030)
6.2 North America Anti-IgG antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-IgG antibody Market Size by Country (2019-2024)
6.4 North America Anti-IgG antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-IgG antibody Market Size (2019-2030)
7.2 Europe Anti-IgG antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-IgG antibody Market Size by Country (2019-2024)
7.4 Europe Anti-IgG antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-IgG antibody Market Size (2019-2030)
8.2 Asia-Pacific Anti-IgG antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-IgG antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-IgG antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-IgG antibody Market Size (2019-2030)
9.2 Latin America Anti-IgG antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-IgG antibody Market Size by Country (2019-2024)
9.4 Latin America Anti-IgG antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-IgG antibody Market Size (2019-2030)
10.2 Middle East & Africa Anti-IgG antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-IgG antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-IgG antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BosterBio
11.1.1 BosterBio Company Detail
11.1.2 BosterBio Business Overview
11.1.3 BosterBio Anti-IgG antibody Introduction
11.1.4 BosterBio Revenue in Anti-IgG antibody Business (2019-2024)
11.1.5 BosterBio Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Anti-IgG antibody Introduction
11.2.4 Bio-Rad Revenue in Anti-IgG antibody Business (2019-2024)
11.2.5 Bio-Rad Recent Development
11.3 ProSci
11.3.1 ProSci Company Detail
11.3.2 ProSci Business Overview
11.3.3 ProSci Anti-IgG antibody Introduction
11.3.4 ProSci Revenue in Anti-IgG antibody Business (2019-2024)
11.3.5 ProSci Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Detail
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences Anti-IgG antibody Introduction
11.4.4 BD Biosciences Revenue in Anti-IgG antibody Business (2019-2024)
11.4.5 BD Biosciences Recent Development
11.5 Biorbyt
11.5.1 Biorbyt Company Detail
11.5.2 Biorbyt Business Overview
11.5.3 Biorbyt Anti-IgG antibody Introduction
11.5.4 Biorbyt Revenue in Anti-IgG antibody Business (2019-2024)
11.5.5 Biorbyt Recent Development
11.6 R&D Systems
11.6.1 R&D Systems Company Detail
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Anti-IgG antibody Introduction
11.6.4 R&D Systems Revenue in Anti-IgG antibody Business (2019-2024)
11.6.5 R&D Systems Recent Development
11.7 Bethyl Laboratories
11.7.1 Bethyl Laboratories Company Detail
11.7.2 Bethyl Laboratories Business Overview
11.7.3 Bethyl Laboratories Anti-IgG antibody Introduction
11.7.4 Bethyl Laboratories Revenue in Anti-IgG antibody Business (2019-2024)
11.7.5 Bethyl Laboratories Recent Development
11.8 Dianova
11.8.1 Dianova Company Detail
11.8.2 Dianova Business Overview
11.8.3 Dianova Anti-IgG antibody Introduction
11.8.4 Dianova Revenue in Anti-IgG antibody Business (2019-2024)
11.8.5 Dianova Recent Development
11.9 BioLegend
11.9.1 BioLegend Company Detail
11.9.2 BioLegend Business Overview
11.9.3 BioLegend Anti-IgG antibody Introduction
11.9.4 BioLegend Revenue in Anti-IgG antibody Business (2019-2024)
11.9.5 BioLegend Recent Development
11.10 Abbexa
11.10.1 Abbexa Company Detail
11.10.2 Abbexa Business Overview
11.10.3 Abbexa Anti-IgG antibody Introduction
11.10.4 Abbexa Revenue in Anti-IgG antibody Business (2019-2024)
11.10.5 Abbexa Recent Development
11.11 SouthernBiotech
11.11.1 SouthernBiotech Company Detail
11.11.2 SouthernBiotech Business Overview
11.11.3 SouthernBiotech Anti-IgG antibody Introduction
11.11.4 SouthernBiotech Revenue in Anti-IgG antibody Business (2019-2024)
11.11.5 SouthernBiotech Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Anti-IgG antibody Introduction
11.12.4 Thermo Fisher Scientific Revenue in Anti-IgG antibody Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Immundiagnostik
11.13.1 Immundiagnostik Company Detail
11.13.2 Immundiagnostik Business Overview
11.13.3 Immundiagnostik Anti-IgG antibody Introduction
11.13.4 Immundiagnostik Revenue in Anti-IgG antibody Business (2019-2024)
11.13.5 Immundiagnostik Recent Development
11.14 MyBioSource
11.14.1 MyBioSource Company Detail
11.14.2 MyBioSource Business Overview
11.14.3 MyBioSource Anti-IgG antibody Introduction
11.14.4 MyBioSource Revenue in Anti-IgG antibody Business (2019-2024)
11.14.5 MyBioSource Recent Development
11.15 BMA Biomedicals
11.15.1 BMA Biomedicals Company Detail
11.15.2 BMA Biomedicals Business Overview
11.15.3 BMA Biomedicals Anti-IgG antibody Introduction
11.15.4 BMA Biomedicals Revenue in Anti-IgG antibody Business (2019-2024)
11.15.5 BMA Biomedicals Recent Development
11.16 Novus Biologicals
11.16.1 Novus Biologicals Company Detail
11.16.2 Novus Biologicals Business Overview
11.16.3 Novus Biologicals Anti-IgG antibody Introduction
11.16.4 Novus Biologicals Revenue in Anti-IgG antibody Business (2019-2024)
11.16.5 Novus Biologicals Recent Development
11.17 Cell Sciences
11.17.1 Cell Sciences Company Detail
11.17.2 Cell Sciences Business Overview
11.17.3 Cell Sciences Anti-IgG antibody Introduction
11.17.4 Cell Sciences Revenue in Anti-IgG antibody Business (2019-2024)
11.17.5 Cell Sciences Recent Development
11.18 Rockland Immunochemicals
11.18.1 Rockland Immunochemicals Company Detail
11.18.2 Rockland Immunochemicals Business Overview
11.18.3 Rockland Immunochemicals Anti-IgG antibody Introduction
11.18.4 Rockland Immunochemicals Revenue in Anti-IgG antibody Business (2019-2024)
11.18.5 Rockland Immunochemicals Recent Development
11.19 QED Bioscience
11.19.1 QED Bioscience Company Detail
11.19.2 QED Bioscience Business Overview
11.19.3 QED Bioscience Anti-IgG antibody Introduction
11.19.4 QED Bioscience Revenue in Anti-IgG antibody Business (2019-2024)
11.19.5 QED Bioscience Recent Development
11.20 Miltenyi Biotec
11.20.1 Miltenyi Biotec Company Detail
11.20.2 Miltenyi Biotec Business Overview
11.20.3 Miltenyi Biotec Anti-IgG antibody Introduction
11.20.4 Miltenyi Biotec Revenue in Anti-IgG antibody Business (2019-2024)
11.20.5 Miltenyi Biotec Recent Development
11.21 Jackson ImmunoResearch Laboratories
11.21.1 Jackson ImmunoResearch Laboratories Company Detail
11.21.2 Jackson ImmunoResearch Laboratories Business Overview
11.21.3 Jackson ImmunoResearch Laboratories Anti-IgG antibody Introduction
11.21.4 Jackson ImmunoResearch Laboratories Revenue in Anti-IgG antibody Business (2019-2024)
11.21.5 Jackson ImmunoResearch Laboratories Recent Development
11.22 Advansta
11.22.1 Advansta Company Detail
11.22.2 Advansta Business Overview
11.22.3 Advansta Anti-IgG antibody Introduction
11.22.4 Advansta Revenue in Anti-IgG antibody Business (2019-2024)
11.22.5 Advansta Recent Development
11.23 Affinity Immuno
11.23.1 Affinity Immuno Company Detail
11.23.2 Affinity Immuno Business Overview
11.23.3 Affinity Immuno Anti-IgG antibody Introduction
11.23.4 Affinity Immuno Revenue in Anti-IgG antibody Business (2019-2024)
11.23.5 Affinity Immuno Recent Development
11.24 Antigenix America
11.24.1 Antigenix America Company Detail
11.24.2 Antigenix America Business Overview
11.24.3 Antigenix America Anti-IgG antibody Introduction
11.24.4 Antigenix America Revenue in Anti-IgG antibody Business (2019-2024)
11.24.5 Antigenix America Recent Development
11.25 Promega
11.25.1 Promega Company Detail
11.25.2 Promega Business Overview
11.25.3 Promega Anti-IgG antibody Introduction
11.25.4 Promega Revenue in Anti-IgG antibody Business (2019-2024)
11.25.5 Promega Recent Development
11.26 Abeomics
11.26.1 Abeomics Company Detail
11.26.2 Abeomics Business Overview
11.26.3 Abeomics Anti-IgG antibody Introduction
11.26.4 Abeomics Revenue in Anti-IgG antibody Business (2019-2024)
11.26.5 Abeomics Recent Development
11.27 Anogen
11.27.1 Anogen Company Detail
11.27.2 Anogen Business Overview
11.27.3 Anogen Anti-IgG antibody Introduction
11.27.4 Anogen Revenue in Anti-IgG antibody Business (2019-2024)
11.27.5 Anogen Recent Development
11.28 AIVD Biotech
11.28.1 AIVD Biotech Company Detail
11.28.2 AIVD Biotech Business Overview
11.28.3 AIVD Biotech Anti-IgG antibody Introduction
11.28.4 AIVD Biotech Revenue in Anti-IgG antibody Business (2019-2024)
11.28.5 AIVD Biotech Recent Development
11.29 Sino Biological
11.29.1 Sino Biological Company Detail
11.29.2 Sino Biological Business Overview
11.29.3 Sino Biological Anti-IgG antibody Introduction
11.29.4 Sino Biological Revenue in Anti-IgG antibody Business (2019-2024)
11.29.5 Sino Biological Recent Development
11.30 Tonbo Biosciences
11.30.1 Tonbo Biosciences Company Detail
11.30.2 Tonbo Biosciences Business Overview
11.30.3 Tonbo Biosciences Anti-IgG antibody Introduction
11.30.4 Tonbo Biosciences Revenue in Anti-IgG antibody Business (2019-2024)
11.30.5 Tonbo Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock